Shearman & Sterling represented the initial purchasers, led by Citigroup Global Markets Inc., HSBC Securities (USA) Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and RBS Securities Inc., as Joint Bookrunning Managers on Reckitt Benckiser’s inaugural US dollar bond offering, in a private placement of US$1 billion aggregate principal amount of notes offered by Reckitt Benckiser Treasury Services plc and guaranteed by Reckitt Benckiser Group plc.
Reckitt Benckiser is a global consumer goods leader in health, hygiene and home and is in the top 25 of FTSE 100 companies. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands, including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil, Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, and French’s.
The Shearman & Sterling team of lawyers in the firm’s London, Washington, DC, and Frankfurt offices included London Capital Markets partner Richard Price and associates Ellen Shiels, Jason Banks, Lulu Zhou, and Ana Stefanovic Grbec; London Tax partner Iain Scoon, counsel Simon Letherman and associate Jack Prytherch; Washington, DC Tax partner Kristen Garry and associates Melissa Henkel, Judy Fisher, and Mary Jo Lang; London Environmental counsel Mehran Massih; London Financial Institutions Advisory & Financial Regulatory associate Oliver Linch and Frankfurt associate Hartmut Häselbarth.
